DeCure for Corpus callosum agenesis-abnormal genitalia syndrome
DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for corpus callosum agenesis-abnormal genitalia syndrome — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleCorpus callosum agenesis-abnormal genitalia syndrome maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for corpus callosum agenesis-abnormal genitalia syndrome is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
SMG6 nonsense mediated mRNA decay factor (SMG6) — SMG6 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 4UM2 · 2.1 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
The 1964 report describes a family in which partial agenesis of the corpus callosum was transmitted in a sex-linked recessive pattern, affecting five male infants. All five had seizures within hours of birth and severe developmental retardation; three had died by the time of the report. A 1985 prospective study followed 40 children with partial agenesis for up to 15 years. At diagnosis most were developmentally delayed or retarded. When the condition was diagnosed in infancy, most children had or later developed seizures. Older patients had a more favourable outcome and were less likely to develop epilepsy.
A 2019 case report describes a patient with partial agenesis who had depressed mood, transient memory loss, and a history of cognitive, social, and behavioural disturbances beginning in childhood. The authors reviewed the literature and noted that agenesis of the corpus callosum has been linked to psychiatric disorders, cognitive deficits, learning disabilities, and developmental delays. A 1980 case reported a male infant with agenesis, an abnormal phenotype, mental retardation, and chromosome mosaicism 46,XY/47,XY with an extra ring chromosome of undetermined origin; the parents had normal karyotypes.
A 1969 paper reported a 12-month-old male with agenesis diagnosed by pneumoencephalography who did not have seizures, which the authors noted was unusual for this anomaly. Across these reports, the condition is rare, often associated with early seizures and developmental delay, but outcomes vary with age at diagnosis. No drug treatment is mentioned in any of the abstracts.
What is still missing is any systematic trial of a therapeutic intervention, any biomarker to stratify patients by prognosis, and the funding to assemble a cohort large enough to test whether early seizure control or other supportive measures alter the long-term course.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Archives of Neurology · 1964 · 80 citations
Hereditary Partial Agenesis of Corpus Callosum
AbstractWhile sporadically appearing agenesis of the corpus callosum is a relatively common entity, a genetic form of this condition has, to our knowledge, not been known to occur in man. We, therefore, wish to describe a family in whom this anomaly was transmitted in a sex-linked, recessive manner, affecting five male infants. In each instance, the disease manifested itself by seizures commencing within a few hours of birth and by severe developmental retardation. At the time of writing, three of the patients have succumbed. Neuropathological and neurochemical findings on one are herewith presented. <h3>Report of Cases</h3> One patient, III-13, was examined personally; data regarding the four others were obtained from medical records and family interviews. Case 1 (Index Case, III-13).—This was a white male, born March 9, 1961. Pregnancy and delivery were completely normal. Birth weight was 8 lb 5 oz (3.7 kg). At 60 hours of age, the infant
American journal of diseases of children · 1985 · 52 citations
Agenesis of the Corpus Callosum
AbstractForty children with partial agenesis of the corpus callosum have been prospectively identified and followed up for up to 15 years. Additional physical anomalies and diagnoses were frequent. At the time of diagnosis, the majority of children were developmentally delayed or retarded. If callosal agenesis was diagnosed during infancy, most children had or subsequently developed seizures. Older patients had a more favorable outcome and were less likely to develop epilepsy.
Case Reports in Psychiatry · 2019 · 17 citations · open access
Neuropsychiatric Manifestations of Partial Agenesis of the Corpus Callosum: A Case Report and Literature Review
AbstractAgenesis of the corpus callosum is a rare congenital defect that has been linked to psychiatric disorders, cognitive deficits, learning disabilities, and developmental delays. We present the case of a patient with partial agenesis of the corpus callosum who exhibits depressed mood, transient loss of memory, and history of cognitive, social, and behavioral disturbances that developed during his childhood. Recent and pertinent literature was reviewed and the agenesis of the corpus callosum and its associated neuropsychiatric manifestations are discussed.
Journal of Medical Genetics · 1980 · 6 citations · open access
Agenesis of the corpus callosum with mosaicism 46,XY/47,XY, extra ring chromosome.
AbstractA case of agenesis of the corpus callosum with a chromosomal abnormality is reported. The patient was a male infant, born to phenotypically normal, non-consanguineous parents. He had an abnormal phenotype, mental retardation, and chromosome mosaicism 46,XY/47,XY,+r. Chromosomal analysis of both parents showed a normal karotype. The origin of the small ring chromosome could not be determined and it is difficult to relate the phenotype of the infant to the cytogenetic findings.
The journal of the Japanese Practical Surgeon Society · 1969 · 0 citations · open access
Agenesis of the Corpus Callosum Diagnosed by Pneumoencephalography
AbstractAgenesis of the corpus callosum is a rare congenital anomaly. Since Reil reported the first case of this anomaly in 1812, 130 cases which were confirmed patho-anatomically, have been reported. In 1934, however, Davidoff et al. & penfield et al. had diagnosed the agenesis of corpus callosum only by pneumoencephalography, before patho-anatomical reference. Since then, 60 cases which have been diagnosed only by pneumoencephalography, were reported. In this paper, a living case of agenesis of corpus callosum, 12 months old, male child was presented. This case showed the characteristic apperances of pneumoencephalographic findings due to agenesis of corpus callosum. It was also interesting that the patient did not have any seizures which is generally common in most of this anomaly.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
